
Lawsuit investigates ADMA Biologics over alleged misleading revenue claims after stock plunge.
Rosen Law Firm is investigating ADMA Biologics for allegedly issuing misleading business information that caused its stock to drop 16.6% after a short seller accused the company of inflating revenue through channel stuffing. Investors who bought ADMA...
